Strengthening its over the counter (OTC) portfolio, Pharma major Dr. Reddy's Laboratories on Monday, November 2, 2015, announced the launch of Nise D spray, which offers quick and targeted pain relief. The company said, "Through this product, Dr. Reddy's has further expanded its offerings in the therapeutic area of pain relief to consumers."
In India, the market for pain relief products is approximately Rs. 1,700 crore. Pain relief sprays are growing 20 times faster than creams and gels. This indicates a trend of changing consumer preferences.
‘Nise has been providing effective relief to consumers by killing pain for several years. With a growing consumer preference for pain relief sprays, Dr. Reddy's has launched Nise D spray for quick and targeted pain relief.’
AdvertisementThe formulation for Nise D Spray comprises of three key ingredients which get absorbed quicker, penetrate deep to reach the source of pain and reduce inflammation. Nise, as a brand has been providing effective relief to consumers by killing pain for several years.
Dr. Reddy's executive vice president and head, branded markets (India & Emerging countries) M.V. Ramana, said, "Nise D Spray marks our entry into the new segment and further boosts our OTC portfolio. Nise gel has made a remarkable headway into the market and looking at the market dynamics and consumer requirements, we expect Nise D Spray to have a great momentum and significant market share across regions."